Cilnidipine
From Wikipedia, the free encyclopedia
|
Cilnidipine
|
|
| Systematic (IUPAC) name | |
| O3-(2-methoxyethyl) O5-[(E)-3-phenylprop-2-enyl] 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine- 3,5-dicarboxylate | |
| Identifiers | |
| CAS number | ? |
| ATC code | C08 |
| PubChem | |
| Chemical data | |
| Formula | C27H28N2O7 |
| Mol. mass | 492.52 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Cilnidipine (INN) is a calcium channel blocker.
|
|||||||||||

